Specialty Pharmacy

Top news of the week from The American Journal of Pharmacy Benefits.

A combination therapy that attacks the viral reservoir may be crucial to controlling HIV replication without medication.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Pharmacists are medication experts who play an integral role in the health care team. I am honored to be a pharmacist and believe that we are lifelong learners.

Top news of the week from Specialty Pharmacy Times.

Top news of the day from across the health care landscape.

John Giannouris, vice president, Specialty Pharmacy Services, ValueCentric, speaks about how specialty pharmacies and other stakeholders can harness patient data to improve outcomes.

Basic Care's products are cheaper to buy in bulk compared with other store brands.

Cigna to acquire major pharmacy benefit manager for $67 billion.

New research may overcome hurdles to eliminating viral reservoirs that prevent curing HIV.

Patients between 18 and 24 years of age with IBD may have a greater risk of heart attacks.

Malignant peripheral nerve sheath tumors are currently incurable.

Top news of the day from across the health care landscape.

News and internet forums are filled with ride-sharing drivers who have taken patients to the hospital or the doctors.

First Abbreviated New Drug Application filed for sofosbuvir (Sovaldi).

FDA approves shorter administration periods and new dosing options for nivolumab (Opdivo).

Research into gene variants may improve targeted treatments for pancreatic cancer.

Top news of the day from across the health care landscape.

Brandon Newman, PharmD, CSP, Program Director, Vanderbilt Specialty Pharmacy, speaks to the benefits of becoming a certified specialty pharmacist.

The risk of HIV Infection may increase during and after pregnancy, a new study suggests.

The aging HIV population presents challenges to health care providers.

Officials with the FDA have approved ibalizumab-uiyk (Trogarzo, TaiMed Biologics), the first antiretroviral medication for adults with HIV who cannot be successfully treated with other therapies.

Mylan will reduce the wholesale acquisition costs of Smyfi Lo and Cimduo, which are both combination therapies for HIV.

Targeting an energy-related molecule could prevent the onset of autoimmune diseases.

A new direct-to-consumer test analyzes saliva for 3 BRCA variants that may elevate the risk of various types of cancer.

HIV packages a key viral protein in exosomes to transport throughout the body.

An enzyme blockade could assist remyelination in patients with peripheral nerve damage.

Top news of the day from across the health care landscape.

New study findings suggest that more at-risk individuals should take pre-exposure prophylaxis to prevent HIV.

In an effort to evaluate whether switching from a reference biologic to a biosimilar could lead to altered clinical outcome, a research team, led by Hillel Cohen, PhD, conducted a systematic literature review of all available switching studies.